Poor
Mostly Aligned
Patient Risk:
Low
Summary
Only two clinical claims align with label content provided (indication and mechanism). All other claims concern pricing, discounts/rebates, and program availability, which are not supported by the provided FDA label sections and thus are largely off-label-information.
Category Scores
Accurate Statements
Yervoy (ipilimumab) is a medication used to treat certain types of skin cancer, including melanoma.
Supported in part by Indications and Usage (1.1 Unresectable or Metastatic Melanoma; 1.2 Adjuvant Treatment of Melanoma).
Yervoy works by boosting the body's immune system to fight cancer cells.
Supported by Mechanism of Action (12.1), describing CTLA-4 blockade leading to augmented T-cell activation/proliferation and anti-tumor immune response.
Unsupported Statements
The average wholesale price of Yervoy in the United States is around $120,000 per year.
Absent from the label sections provided.
Bristol-Myers Squibb, the manufacturer of Yervoy, offers discounts and rebates to eligible patients.
Absent from the label sections provided.
Non-profit organizations and patient advocacy groups offer financial assistance and discounts to patients in need.
Absent from the label sections provided.
Government programs such as Medicaid and Medicare offer discounts and savings to eligible patients.
Absent from the label sections provided.
Some pharmacies offer discounts and savings on Yervoy.
Absent from the label sections provided.
Yervoy discounts can reduce patients' out-of-pocket costs.
Absent from the label sections provided.
Discounts and savings programs can increase patients' access to Yervoy.
Absent from the label sections provided.
By increasing access to Yervoy, discounts and savings programs can improve health outcomes for patients with advanced melanoma.
Absent from the label sections provided.
Bristol-Myers Squibb's Patient Assistance Program reduces the cost of Yervoy by up to 75%.
Absent from the label sections provided.
The Melanoma Research Foundation's Patient Assistance Program offers financial assistance and discounts to patients with melanoma, including those taking Yervoy.
Absent from the label sections provided.
Medicare Part D offers discounts and savings on Yervoy for eligible Medicare patients.
Absent from the label sections provided.
Some programs offer discounts of up to 75%.
Absent from the label sections provided.
Yervoy discounts are typically only available for patients who meet certain eligibility criteria, such as income level or insurance status.
Absent from the label sections provided.
Some pharmacies offer discounts and savings on Yervoy.
Absent from the label sections provided.
Yervoy discounts may be available in other countries as well.
Absent from the label sections provided.
Contradictions
Important Omissions
Dosage and administration details (2) were not provided for audit from the AI response claim set.
Importance:
Moderate
Contraindications (4) were not addressed in the provided claim set.
Importance:
Moderate
Warnings and precautions (5), including any boxed warnings, were not addressed in the provided claim set.
Importance:
Moderate
Adverse reactions (6) were not addressed in the provided claim set.
Importance:
Moderate
Use in specific populations (e.g., pediatric/pregnancy) was not addressed in the provided claim set.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
No dosing, contraindication, boxed warning, or safety-critical statements were included in the provided claim set; however, the presence of multiple unsupported financial/access claims reduces label-alignment compliance.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Mostly Aligned
Primary Issue
Multiple claims about pricing, discounts/rebates, patient assistance programs, and program eligibility are not supported by the provided FDA label sections.
Suggested Improvement
Limit content to FDA label-supported information (e.g., indications and mechanism) and remove or qualify any pricing/access/assistance claims unless supported by the provided label text.